CanSino Checking Vaccine Safety More Closely, Chairman Says
Bloomberg 2 hrs ago
(Bloomberg)
CanSino Biologics Inc. is monitoring its Covid-19 vaccine more carefully after cases of blood clots forced other suppliers to suspend inoculations.
“We’re just monitoring more cautiously,” CanSino Chairman Yu Xuefeng said on the sidelines of the Boao Forum in Hainan, China.
“As a vaccine developer we are closely watching what’s going on,” Yu said. “But we haven’t really found anything in our vaccine linking to this.”
The comments come as a vaccine from Johnson & Johnson was halted in Europe after U.S. officials paused immunizations to investigate blood clots suffered by six women. The rare cases of blood-clotting threaten to slow the roll-out of inoculations as regulators and vaccine suppliers review safety.
Fauci Predicts Warning, Not Cancellation, for Johnson & Johnson Vaccine
Dr. Anthony Fauci on Sunday predicted that a warning will be applied to the Johnson & Johnson COVID-19 vaccine after health officials recommended pausing usage last week rather than it being canceled altogether.
“I doubt very seriously if they just cancel it. I don’t think that’s going to happen. I do think that there will likely be some sort of warning or restriction or risk assessment,” Fauci, who is the head of the U.S. National Institute of Allergy and Infectious Diseases, told “Meet the Press.”
The Centers for Disease Control and Prevention’s (CDC) advisory panel will again meet next week on how to handle the vaccine. Both the CDC and Food and Drug Administration (FDA) recommended halting usage of the vaccine amid isolated reports of blood clots. The advisory panel met on April 14 but delayed a vote on whether to limit the single-shot J&J vaccine based on age or sex.
Meet The Press/NBC
Fauci said Sunday that a decision on booster shots could be made by the end of the summer.
Dr. Anthony Fauci said Sunday that a COVID-19 booster shot could be necessary for the future.
Pharmaceutical companies Pfizer and Moderna have said a third shot may be necessary.
Fauci said that decision would be made by public health officials and not pharmaceutical companies.
Dr. Anthony Fauci, the longtime director of the US National Institute of Allergy and Infectious Diseases, said Sunday that the decision about whether a COVID-19 vaccine booster shot would be needed would be made by public health officials and not by pharmaceutical companies.